Food and Drug Regulations, C.R.C., c. 870
Section C.03.305
Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.03.305 · current to June 17, 2026 · regulation last amended June 17, 2026
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) A study shall meet all of the following requirements:
(a) before the study drug is used in the study, there is sufficient data from testing it in animals and humans to demonstrate its safety in humans;
(b) the amount of active ingredients or combination of active ingredients in the study drug has been shown not to cause any clinically detectable pharmacodynamic effect in humans;
(c) the total radiation dose incurred annually by a study subject, including from multiple administrations of the study drug, from significant contaminants or from impurities and from the use of other procedures for the purposes of the study, will be not more than 50 mSv;
(d) any concomitant drug used in the study has been assigned a drug identification number under subsection C.01.014.2(1) or, in the case of a concomitant drug that is a new drug, has been issued a notice of compliance under section C.08.004;
(e) study subjects shall be at least 18 years old and have legal capacity at the time of the study;
(f) female study subjects shall
(i) be confirmed at the outset of the study, on the basis of a pregnancy test, as not being pregnant or state in writing that they are not pregnant, and
(ii) be advised that if they are lactating, they are to suspend lactation for 24 hours after the administration of the study drug; and
(g) the study shall not involve more than 30 study subjects.
(2) Despite paragraph (1)(g), a study may involve more than 30 study subjects if the sponsor provides the Minister with a scientific rationale for the increase and the Minister approves it.
Read the Food and Drug Regulations on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.